Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines (CabACC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03257891
Recruitment Status : Recruiting
First Posted : August 22, 2017
Last Update Posted : April 11, 2018
Sponsor:
Collaborator:
San Luigi Gonzaga Hospital
Information provided by (Responsible Party):
Alfredo Berruti, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 24, 2021
Estimated Study Completion Date : January 24, 2022
Publications of Results: